SEC Form 4 · accession 0001140361-18-035892

IDEXX LABORATORIES INC /DE · IDXX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Aug 3, 2018

Accepted (ET)

Aug 7, 2018 · 6:01 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000874716

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Aug 3, 2018	M	2,952	$46.91	A	9,127	D
Common Stock	Aug 3, 2018	S	1,515	$240.6418	D	7,612	D
Common Stock	Aug 3, 2018	M	2,986	$64.69	A	10,598	D
Common Stock	Aug 3, 2018	S	1,750	$240.6418	D	8,848	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right-to-buy)^F3,F1	$46.91	Aug 3, 2018	M	2,952	D	—	Aug 31, 2023	Common Stock	2,952	0	D
Non-Qualified Stock Option (right-to-buy)^F3,F2	$64.69	Aug 3, 2018	M	2,986	D	—	May 6, 2024	Common Stock	2,986	2,988	D

F1Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 3,476 shares on May 7, 2014, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
F2Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 2,987 shares on May 7, 2015, without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
F3Not applicable.